Lesson plan
R-Pharm
R-Pharm ( ) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
Article summary
R-Pharm ( ) is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection. It was founded by Alexey Repik (ru) in 2001, but has had an increasingly international operations base since, with Japanese Corporation Mitsui & Co., Ltd. acquiring 10% of its shares in 2017. In 2022, against the background of the introduction of personal sanctions, Alexey Repik resigned from the owners of R-Pharm, selling his share in the company to the management of R-Pharm, and resigned as chairman of the board of directors.
Key claims
- date of foundation: 2001 — source: Wikipedia, revision 1376542423, retrieved 2026-10-20 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the date of foundation is "2001". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
- Wikipedia, “R-Pharm”, revision 1376542423, retrieved 2026-10-20 https://en.wikipedia.org/w/index.php?oldid=1376542423
Key claims and bibliography are generated from the same tracked claims and sources as the article page.